Moderna Vaccine Approved for Teenagers in EU

The European Medicines Agency has approved the Moderna vaccine for teens aged between 12-17 years. And Moderna is becoming the second one getting such approval after Pfizer BioNTech in May this year reported by BBC and Reuters.

Use of the vaccine, Spikevax, will be the same in adolescents as in people over 18, the European Medicines Agency (EMA) said, adding the shot produced a comparable antibody response to that seen in 18- to 25-year-olds.

The EMA said the two-dose vaccine is given four weeks apart, and its human medicines committee's recommendation was based on a study of 3,732 participants.

The CDC suggests getting a COVID-19 vaccine for your child as soon as possible and they give some ins and outs of teens vaccination. But they concerned guardians about the second dose of vaccine after administration sales of myocarditis and pericarditis in adolescents and young adults have been reported more often after getting the second dose than after the first dose of one of these two mRNA COVID-19 vaccines.

Vaccinations schedule in case of Pfizer BioNTech: 

Get a second shot of the Vaccine 3 weeks after their first shot.

Vaccinations schedule in case of Moderna:

Moderna said on Friday it had submitted data to authorities around the world and expects authorizations for adolescents in the coming weeks.

As CDC, EMA, Pfizer and Moderna has confirmed this teens vaccine is safe and effective,
So don't hesitate to grab the opportunity to get your teens child vaccinated.

The Pfizer-BioNTech Covid-19 vaccine was found to be 100% efficacious in preventing symptomatic Covid-19 in children ages 12 to 15 years. Photo / Getty Images